Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andre Lukas who wrote (1885)	9/29/1997 1:21:00 PM
From: Henry Niman	of 6136

Andre. You should read the AGPH article that came out this morning in thestreet.com ( thestreet.com ). An abstract to be present at anti-viral conference indicates Viracept's resistance profile isn't as solid as some think. Patients who develop reistance to Viracept subsequently have resistance to other PI's. Study is small and viral load is relatively high at time of switch, but other PIs had no effect (viral load kept increasing).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next